Mitochondrial preemptive medicine, MOONSHOT research & development program

Health and longevity through
the improvement of mitochondrial function

Outline of Research

By comprehensively and integratively analyzing the "mitochondria-gut bacteria interaction," in which mitochondria and intestinal bacteria work together to regulate human health, we will clarify the regulatory mechanisms and develop non-invasive diagnostic methods and new therapeutic agents for mitochondrial function. By 2040, we aim to create a society where healthy longevity is achieved until the age of 100 through early detection of mitochondrial dysfunction and early intervention and treatment with diet, exercise, and medication.

Overview and illustration explanation

Press Release

NEWS

Press Release Stories

Source:AMED Official Channel

Symposium

Source:AMED Official Channel

Introduction

Notice of the start of clinical trials of the mitochondrial disease therapeutic agent MA-5 for healthy adults.



Press Release Stories#1
Phase 1 trial of MA-5 for mitochondrial diseases

Source:AMED Official Channel

-Moonshot Goal 7 Symposium 2022-
Toward the Realization of Medical Care that Enables People to Live Healthy Even at Age 100.

Source:AMED Official Channel

Introduction to Mitochondrial preemptive medicine

To Page Top